245 related articles for article (PubMed ID: 24257427)
41. An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.
Langley JM; Gantt S; Halperin SA; Ward B; McNeil S; Ye L; Cai Y; Smith B; Anderson DE; Mitoma FD
Vaccine; 2024 Jan; 42(3):713-722. PubMed ID: 38142214
[TBL] [Abstract][Full Text] [Related]
42. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
[TBL] [Abstract][Full Text] [Related]
43. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
44. A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.
Choi KY; El-Hamdi NS; McGregor A
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33729125
[TBL] [Abstract][Full Text] [Related]
45. Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.
Cui X; Adler SP; Schleiss MR; Arav-Boger R; Demmler Harrison GJ; McVoy MA
Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404573
[TBL] [Abstract][Full Text] [Related]
46. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
47. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
[TBL] [Abstract][Full Text] [Related]
48. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
[TBL] [Abstract][Full Text] [Related]
49. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
[TBL] [Abstract][Full Text] [Related]
50. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
Gerna G; Lilleri D
New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
[TBL] [Abstract][Full Text] [Related]
51. Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.
Cayatte C; Schneider-Ohrum K; Wang Z; Irrinki A; Nguyen N; Lu J; Nelson C; Servat E; Gemmell L; Citkowicz A; Liu Y; Hayes G; Woo J; Van Nest G; Jin H; Duke G; McCormick AL
J Virol; 2013 Oct; 87(20):11107-20. PubMed ID: 23926341
[TBL] [Abstract][Full Text] [Related]
52. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
[TBL] [Abstract][Full Text] [Related]
53. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.
Pass RF; Burke RL
Semin Pediatr Infect Dis; 2002 Jul; 13(3):196-204. PubMed ID: 12199616
[TBL] [Abstract][Full Text] [Related]
54. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
55. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
[TBL] [Abstract][Full Text] [Related]
56. Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus.
Finnefrock AC; Freed DC; Tang A; Li F; He X; Wu C; Nahas D; Wang D; Fu TM
Hum Vaccin Immunother; 2016 Aug; 12(8):2106-2112. PubMed ID: 26986197
[TBL] [Abstract][Full Text] [Related]
57. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).
Schleiss MR
J Clin Virol; 2002 Aug; 25 Suppl 2():S37-49. PubMed ID: 12361755
[TBL] [Abstract][Full Text] [Related]
58. Neutralizing activity of saliva against cytomegalovirus.
Saccoccio FM; Gallagher MK; Adler SP; McVoy MA
Clin Vaccine Immunol; 2011 Sep; 18(9):1536-42. PubMed ID: 21795465
[TBL] [Abstract][Full Text] [Related]
59. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
[TBL] [Abstract][Full Text] [Related]
60. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
